Regenerative Medical Technology (RMTG) Receivables - Other (2021 - 2022)
Regenerative Medical Technology (RMTG) posted quarterly Receivables - Other of $86262.0 for Q3 2022, up 399.87% quarter-over-quarter from $17257.0 in Q4 2021.
Regenerative Medical Technology (RMTG) Receivables - Other (2021 - 2022) Analysis & Trends
Regenerative Medical Technology's Receivables - Other history runs 2 years deep, the most recent figure standing at $86262.0 for Q3 2022.
- In Q3 2022, Receivables - Other changed N/A year-over-year to $86262.0; the TTM figure through Sep 2022 stood at $86262.0 (changed N/A YoY), while the FY2021 annual figure was $17257.0, changed N/A from the prior year.
- Receivables - Other for Q3 2022 stood at $86262.0, up from $17257.0 in the prior quarter.
- The five-year high for Receivables - Other was $86262.0 in Q3 2022, with the low at $17257.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Regenerative Medical Technology | 1.58 Mn | 515,228.12 | 1.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 86,262.00 |
| Sep 30, 2022 | 86,262.00 |
| Dec 31, 2021 | 17,257.00 |
| Dec 31, 2021 | 17,257.00 |